宣泰医药
(688247)
| 流通市值：49.60亿 | | | 总市值：49.60亿 |
| 流通股本：4.53亿 | | | 总股本：4.53亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 209,050,861.02 | 148,955,862.02 | 225,785,781.43 | 297,635,969.73 |
| 交易性金融资产 | 534,112,246.52 | 584,452,996.41 | 507,742,124.86 | 450,000,000 |
| 应收票据及应收账款 | 82,119,143.97 | 63,321,304.26 | 103,524,626.45 | 107,413,000.95 |
| 应收账款 | 82,119,143.97 | 63,321,304.26 | 103,524,626.45 | 107,413,000.95 |
| 预付款项 | 9,032,548.9 | 11,378,516.56 | 13,059,733.35 | 14,079,955.42 |
| 其他应收款合计 | 3,656,761.84 | 2,778,063.08 | 2,731,474.01 | 4,862,460.19 |
| 存货 | 100,712,763.05 | 102,397,398.38 | 102,418,450.82 | 107,253,297.36 |
| 合同资产 | 11,338,686.84 | 9,224,879.32 | 7,446,413.64 | 11,091,821.57 |
| 其他流动资产 | 8,014,403.87 | 60,780,066.96 | 13,609,284.63 | 8,788,010.09 |
| 流动资产合计 | 958,037,416.01 | 983,289,086.99 | 976,317,889.19 | 1,001,124,515.31 |
| 非流动资产: | | | | |
| 长期股权投资 | 65,141,985.16 | 64,405,714.41 | 64,416,376.31 | 63,759,966.36 |
| 固定资产 | 297,882,230.19 | 295,362,470.83 | 263,565,659.95 | 247,962,967.87 |
| 在建工程 | 61,111,701.01 | 61,538,657.62 | 80,754,194.31 | 32,533,880.59 |
| 使用权资产 | 53,128.19 | 9,931.07 | 24,827.63 | 39,724.19 |
| 无形资产 | 18,264,604.24 | 19,954,595 | 21,650,482.01 | 22,508,845.51 |
| 商誉 | 18,385,750.74 | 18,385,750.74 | 18,385,750.74 | 18,385,750.74 |
| 长期待摊费用 | 680,440.08 | 814,239.19 | 918,295.28 | 882,974.62 |
| 递延所得税资产 | 18,760,496.93 | 18,958,796.01 | 19,330,308.72 | 17,622,417.22 |
| 其他非流动资产 | 5,095,556.36 | 5,944,503.06 | 7,940,309.06 | 24,652,498.27 |
| 非流动资产合计 | 485,375,892.9 | 485,374,657.93 | 476,986,204.01 | 428,349,025.37 |
| 资产总计 | 1,443,413,308.91 | 1,468,663,744.92 | 1,453,304,093.2 | 1,429,473,540.68 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 21,875,107.81 | 27,611,574.16 | 20,667,815.65 | 21,751,426.17 |
| 应付账款 | 21,875,107.81 | 27,611,574.16 | 20,667,815.65 | 21,751,426.17 |
| 合同负债 | 30,216,454.39 | 37,821,685.35 | 30,440,121.14 | 42,656,632.18 |
| 应付职工薪酬 | 8,833,557.22 | 12,677,618.58 | 24,461,481.93 | 11,038,829.11 |
| 应交税费 | 2,443,683.52 | 7,318,260.49 | 8,881,873.55 | 8,709,191.55 |
| 其他应付款合计 | 7,495,747.63 | 13,325,292.89 | 16,503,119.26 | 26,782,865.79 |
| 应付股利 | - | 1,760,946.75 | 1,760,946.75 | 11,228,847.28 |
| 一年内到期的非流动负债 | 38,187.26 | 6,557.72 | 6,392.93 | 22,087.39 |
| 其他流动负债 | 1,265,608.91 | 2,261,503.76 | 2,225,845.46 | 1,411,356.36 |
| 流动负债合计 | 72,168,346.74 | 101,022,492.95 | 103,186,649.92 | 112,372,388.55 |
| 非流动负债: | | | | |
| 递延收益 | 67,614,014.86 | 71,791,502.21 | 74,719,106.5 | 77,622,918.32 |
| 递延所得税负债 | 2,322,201.15 | 2,356,102.91 | 2,393,999.02 | 2,426,870.72 |
| 非流动负债合计 | 69,936,216.01 | 74,147,605.12 | 77,113,105.52 | 80,049,789.04 |
| 负债合计 | 142,104,562.75 | 175,170,098.07 | 180,299,755.44 | 192,422,177.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 453,340,000 | 453,340,000 | 453,340,000 | 453,340,000 |
| 资本公积 | 512,902,400.27 | 513,570,870.69 | 513,570,870.69 | 512,869,911.23 |
| 减:库存股 | 36,126,025.26 | 36,126,025.26 | 36,126,025.26 | 36,126,025.26 |
| 其他综合收益 | 357.33 | - | - | -120,689.76 |
| 盈余公积 | 32,202,213.54 | 32,202,213.54 | 32,202,213.54 | 24,565,923.73 |
| 未分配利润 | 338,989,800.28 | 330,506,587.88 | 310,017,278.79 | 282,522,243.15 |
| 归属于母公司股东权益合计 | 1,301,308,746.16 | 1,293,493,646.85 | 1,273,004,337.76 | 1,237,051,363.09 |
| 股东权益合计 | 1,301,308,746.16 | 1,293,493,646.85 | 1,273,004,337.76 | 1,237,051,363.09 |
| 负债和股东权益合计 | 1,443,413,308.91 | 1,468,663,744.92 | 1,453,304,093.2 | 1,429,473,540.68 |
| 公告日期 | 2025-08-23 | 2025-04-30 | 2025-04-30 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |